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Abstract
Background: Allelic variation is the cornerstone of genetically determined differences in gene
expression, gene product structure, physiology, and behavior. However, allelic variation,
particularly cryptic (unknown or not annotated) variation, is problematic for follow up analyses.
Polymorphisms result in a high incidence of false positive and false negative results in hybridization
based analyses and hinder the identification of the true variation underlying genetically determined
differences in physiology and behavior. Given the proliferation of mouse genetic models (e.g.,
knockout models, selectively bred lines, heterogeneous stocks derived from standard inbred
strains and wild mice) and the wealth of gene expression microarray and phenotypic studies using
genetic models, the impact of naturally-occurring polymorphisms on these data is critical. With the
advent of next-generation, high-throughput sequencing, we are now in a position to determine to
what extent polymorphisms are currently cryptic in such models and their impact on downstream
analyses.
Results: We sequenced the two most commonly used inbred mouse strains, DBA/2J and C57BL/
6J, across a region of chromosome 1 (171.6 – 174.6 megabases) using two next generation high-
throughput sequencing platforms: Applied Biosystems (SOLiD) and Illumina (Genome Analyzer).
Using the same templates on both platforms, we compared realignments and single nucleotide
polymorphism (SNP) detection with an 80 fold average read depth across platforms and samples.
While public datasets currently annotate 4,527 SNPs between the two strains in this interval,
thorough high-throughput sequencing identified a total of 11,824 SNPs in the interval, including
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7,663 new SNPs. Furthermore, we confirmed 40 missense SNPs and discovered 36 new missense
SNPs.
Conclusion: Comparisons utilizing even two of the best characterized mouse genetic models,
DBA/2J and C57BL/6J, indicate that more than half of naturally-occurring SNPs remain cryptic. The
magnitude of this problem is compounded when using more divergent or poorly annotated genetic
models. This warrants full genomic sequencing of the mouse strains used as genetic models.
Background
With the recent completion of the Perlegen/NIEHS mouse
resequencing [1], over ten million mouse single nucle-
otide polymorphisms (SNPs) are now annotated in the
public databases, resulting in a dramatic increase in the
genome-wide knowledge of variation among 16 of the
most widely used mouse strains. Importantly, this is a
lower bound estimate because the C57BL/6J (B6) strain,
used for the mouse genome reference sequence (NCBI
m37, Apr 2007), is the only mouse strain sequenced in its
entirety. Given the proliferation of mouse genetic models
(e.g., knockout models, selectively bred lines, heterogene-
ous stocks derived from standard inbred strains and wild
mice) and the recent insurgence of gene expression micro-
array and phenotypic studies using these mouse models,
the impact of naturally-occurring polymorphisms on
these data is critical. With the advent of next-generation,
high-throughput sequencing (HTS), we are now in a posi-
tion to determine to what extent polymorphisms remain
cryptic (either undiscovered or not previously annotated
as a SNP in a specific strain comparison) in various mouse
models and assess their impact on downstream analyses.
As an example, we demonstrate that cryptic SNPs are prev-
alent, even between two of the most commonly used and
well-annotated inbred mouse strains, B6 and DBA/2J
(D2).
The onset of next-generation HTS enabled us to obtain
full sequence coverage of a region of chromosome 1 in the
D2 and B6 mouse strains. There are several platforms for
massively parallel DNA sequencing currently on the mar-
ket [2], and we took this opportunity to directly compare
the same dataset on two of the three most widely used
platforms: Illumina (Genome Analyzer) and Applied Bio-
systems (SOLiD). The Genome Analyzer implements a
version of cyclic reversible termination chemistry [3], and
similarly, the SOLiD platform uses a self-checking ligation
chemistry that maps into color space [4]. Both methods
generated short reads that were then realigned to a refer-
ence sequence.
The present analyses were limited to a region of chromo-
some 1 from 171.6 – 174.6 megabases (Mb). This interval
was selected for four reasons. First, it is representative of
the genome in that it spans discrete regions of high and
low SNP densities. Second, it is a gene dense region con-
taining 79 protein coding genes, 2 retrotransposed genes,
and 6 noncoding RNA genes. Third, it harbors numerous
quantitative trait loci (QTLs) affecting a wide variety of
physiological and behavioral phenotypes [for summary,
see [5]]. And finally, the low incidence of annotated poly-
morphisms in a SNP-sparse block has hindered high-res-
olution mapping in this region [6].
We report that comparisons utilizing two well-annotated
mouse genetic models, D2 and B6, predict that more than
half of naturally-occurring SNPs remain unknown or not
annotated. These cryptic SNPs lead to a high incidence of
gene expression microarray false-positive and false-nega-
tive results and lead to failures in identifying allelically-
variant genes that can underlie QTL phenotypic effects.
Results and discussion
D2 BAC contig and sequence
Using 32 PCR probes spanning the 171.6 – 174.6 Mb
interval of chromosome 1, we screened a commercially
available D2 strain bacterial artificial chromosome (BAC)
library, MM_DBa. End-sequencing of the BACs identified
by these PCR probes allowed us to assemble a minimal
overlapping contig of 27 D2 BACs (Figure 1). The result-
ing D2 BAC contig spanned a total of 3.1 Mb from
171,509,721 – 174,625,201 bp on chromosome 1 (Build
37). Contig sequence data from the SOLiD and Genome
Anlayzer platforms were assembled via realignment to the
Ensembl reference sequence [7] and covered the region
surveyed without any large gaps.
B6 BAC contig and sequence
To evaluate our realignment strategy, we sequenced the
corresponding region from the B6 strain, for which full
reference sequence is available [7]. We prepared a B6 con-
tig based on public end-sequence data for BAC clones
from the RPCI-23 library [8]. The resulting B6 BAC contig
spanned 170,806,384 – 174,768,169 bp on chromosome
1 (Figure 1). Using both the SOLiD and Genome Analyzer
datasets we attained realignment coverage with the excep-
tion of two gaps. The first gap (11 kb) was expected since
the RPCI-23 BAC library map lacks annotated coverage in
this region. The second gap (100 kb) could be due to an
error in the mapping of one or two of the RPCI-23 BACs,
since we relied upon reported locations of the B6 BAC
library clones, or, alternatively, could be due to one or twoBMC Genomics 2009, 10:379 http://www.biomedcentral.com/1471-2164/10/379
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clones missing from our pools. These gaps were present in
both assemblies indicating a template problem rather
than a sequencing discrepancy.
Comparison of Applied Biosystems and Illumina sequence 
realignments
Applied Biosytems and Illumina each performed realign-
ments of the D2 and B6 datasets to the public B6 reference
sequence [7]. The SOLiD platform produces short reads
(35 bp) encoded in a color-space format, and Applied Bio-
systems used their realignment pipeline specially
designed to take advantage of this format for color-space
read mapping and downstream analysis including SNP
detection. The Genome Analyzer platform produces short
read (33 bp) datasets with bases encoded in the standard
letter representations, so Illumina carried out a different
realignment approach and ran their dataset through the
Maq [9] pipeline which includes both realignment and
SNP calling procedures. Because both datasets included
only short reads, we did not assess potential insertion/
deletions.
Comparison of our SOLiD and Genome Analyzer
sequence data to the Ensembl reference sequence con-
firmed that the sequence from both platforms is com-
plete. SOLiD generated 31.8 million reads for the pooled
D2 BACs, with 12.4 million (39%) of those mapping to
the chromosome 1 target interval. SOLiD generated 32.7
million reads of pooled B6 BACs with 10.5 million (32%)
mapping to the chromosome 1 interval. Genome Ana-
lyzer generated 14.5 million D2 reads with 9.6 million
(66%) mapping to the chromosome 1 interval, and 14.0
million B6 reads with 6.2 million (44%) mapping to the
chromosome 1 region. Reads that did not align to the
chromosome 1 interval were mostly BAC vector sequence
(which was not removed when preparing the DNA),
adapters from sequencing chemistry, and bacterial con-
tamination. These are template specific problems and do
not reflect upon differences between the sequencing plat-
forms. Additional purification steps would have resulted
in fewer unaligned sequences; however, the aligned
sequences provided sufficient high read depth coverage,
so the exclusion of the unaligned sequences did not
adversely affect the present analyses.
Deep sequencing was achieved, with average read depths
using the Genome Analyzer of 75 and 51 for D2 and B6,
respectively, and 108 and 85, respectively, using SOLiD,
for reads aligning to the chromosome 1 interval (Figure
2). Figure 1 illustrates the BAC contig composition. Each
BAC was pooled equimolarly and, as expected, we saw
higher coverage (i.e., two or more times as many reads) in
the areas where two or more BACs overlap because more
template was included for those regions (Figure 2). We
observed differences in the masking of repetitive
sequences in Applied Biosystems vs. Illumina realign-
ments, suggesting that repetitive regions are problematic
for both platforms with short read sequencing. Paired-end
sequencing was not performed in the present analyses,
but could decipher potential ambiguous, repetitive
regions in future analyses.
B6 reference sequence quality
Although comparison of our custom HTS B6 data to the
B6 reference sequence confirmed the high accuracy of the
reference sequence (≥ 99.998%), we nonetheless identi-
fied a small number of discrepancies in the realignments
to the reference sequence. Upon assembly, the Applied
Biosystems and Illumina realignments of the B6 sequence
reads differed from the B6 reference sequence for 41 and
60 residues (Table 1), respectively; 29 of these differences
were consistent in both datasets when compared to the
reference sequence (Figure 3). Subsequently, based upon
realignment discrepancies called by one or the other plat-
forms, we detected 43 provisional realignment discrepan-
cies between our HTS and the reference sequence.
Sequencing on each the SOLiD and Genome Analyzer
platforms was completed independently, with assembly
algorithms each requiring a minimal depth of 3 reads in
order to confirm an allele call. Quality of the nucleotide
in question, as well as the quality of the surrounding base
calls, was taken into account. Together, these restraints
offer high confidence in the B6 allele calls identified by
both platforms that differ from the references sequence.
Overall, this indicates an exceptionally low discrepancy
rate (only 0.001 – 0.002%) between HTS data and the ref-
erence sequence and also demonstrates the high quality of
the sequence data generated in our analyses. Importantly,
our custom HTS sequence data and the B6 reference strain
sequence were both from RPCI-23 B6 BACs, which were
BAC sequencing coverage Figure 1
BAC sequencing coverage. B6 strain RPCI-23 BACs used 
for genomic sequencing are denoted as white boxes. D2 
strain MM_DBa BACs are indicated as black boxes. Each set 
of BACs is assembled as an overlapping contig. The 3 Mb 
(171.6–174.6 Mb) region used for comparisons is bracketed 
in red.
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generated from a pool of five female B6 mice from the
Jackson Laboratory. Thus, it is extremely unlikely that
strain or template inconsistency contributed to the dis-
crepancies in the realignment of our sequence to the B6
reference sequence.
SNP identification and confirmation
In order to compare the SOLiD and Genome Analyzer
platforms under optimal conditions for each platform
and to compare in a manner the majority of end-users are
likely to employ, the manufacturers used parameters
determined to be optimal for SNP calling on their partic-
ular platform. The Illumina SNP calling method (Maq)
relies upon quality scores and applies a filter based on
these qualities, read depth, and neighboring SNPs in
order to discriminate between a SNP and a base-calling
error. Applied Biosystems calls SNPs based on two-base
encoding in color-space allowing for more sensitive dis-
crimination between SNPs and base-calling errors. Illu-
mina's method produced fewer no calls (Ns) than Applied
Biosystems' method based upon realignments performed
by each vendor (Table 1). No nucleotide bias was appar-
ent in the frequency of the calls using the Genome Ana-
lyzer and SOLiD platforms. We conclude that because of
Maq's probabilistic approach using qualities, more SNPs
are called by Illumina/Maq than by Applied Biosystems;
however, it remains to be confirmed if Illumina has more
false positive calls. It is important to keep in mind that
because the vendors used independent mapping and SNP
calling approaches, differential results due to the platform
cannot be distinguished from those due to the analysis
pipeline.
Currently, the Mouse Phenome Database (MPD), which
includes dbSNP and Perlegen data among other resources,
offers the most inclusive SNP queries for mouse strains,
including comparisons of the D2 and B6 strains (see
Methods for further explanation of SNP Databases).
While, MPD currently annotates 4,527 D2 vs. B6 SNPs in
the chromosome 1 interval (171.6–174.6 Mb), custom
HTS identified 11,824 SNPs (Figure 3) for the same inter-
val (referred to as PARC SNPs because they were
sequenced by one or both platforms in work supported in
part by the Portland Alcohol Research Center, PARC).
9,152 (77%) of the 11,824 PARC SNPs identified by cus-
tom HTS were identified using both the Applied Biosys-
tems and Illumina realignments (i.e., were identified by
two independent experiments) and are therefore of very
high quality (Figure 3). 2,033 (17.2%) PARC SNPs were
identified only by Illumina's realignment, and 639
(5.4%) PARC SNPs were identified only by Applied Bio-
systems realignment. Only 271 (13%) of the Illumina-
specific PARC SNPs and 56 (10%) of the Applied Biosys-
tems-specific PARC SNPs confirmed known SNPs in
MPD.
The SOLiD and Genome Anlayzer datasets were merged
for subsequent comparisons. Our results confirmed 4,161
(92%) of the D2 vs. B6 SNPs currently annotated in the
MPD public dataset within the chromosome 1 interval,
while 236 (5%) of the SNPs reported in MPD for this
interval were determined to be false-positive SNPs. The
130 remaining either lie in gaps in our realignments or
had ambiguous (undetermined or low quality) calls in the
sequence data. Our results identified numerous SNPs not
previously annotated in MPD. In fact, our results identi-
fied 7,663 new SNPs, more than doubling the number of
D2 vs. B6 SNPs found in this chromosome 1 interval.
This chromosome 1 interval spans a clear haplotype
break, resulting in a SNP sparse region (171.6–172.9 Mb)
and a more distal SNP dense region (172.9 – 174.6 Mb)
(Figure 4). The SNP sparse region contains only 16 PARC
SNPs based on our custom sequencing, and the SNP
dense region harbors 11,808 D2 vs. B6 PARC SNPs. This
data further defines the haplotype break between D2 and
B6 and, importantly, provides additional genetic markers
for fine mapping within the SNP-sparse region which pre-
viously was not possible [6]. Additionally, full SNP anno-
tation will inform future SNP array chips allowing for
more precise genotyping.
SNP impact on protein function or expression
We assessed non-synonymous SNPs that result in amino
acid changes in proteins because of their clear impact on
protein activity. Based on our custom HTS, we found 76
missense (non-synonymous coding) PARC SNPs that
changed an amino acid residue between the D2 and B6
strains. 36 of these were new missense SNPs (Table 2).
Confirmation experiments (e.g., transcriptome sequenc-
ing and PCR directed sequencing) and interrogation of
additional datasets [6,10] already have confirmed 30 of
the 36 new missense SNPs (Table 2), with the remaining
six lacking additional data. In an effort to determine
whether the 36 new missense SNPs affect protein func-
tion, we used SIFT (Sorting Intolerant From Tolerant)
[11], which uses sequence homology to predict whether
an amino acid substitution affects protein function, and
PolyPhen (Polymorphism Phenotyping) [12], which uses
multiple sequence alignments and protein 3D structure to
predict protein sequence effects on function. Based on
these two prediction methods, eight of the new missense
SNPs were predicted to affect protein function, although
only one of these amino acid changes was predicted to be
damaging by both methods (Table 2). Our data also con-
firmed 40 missense SNPs annotated in MPD. Finally, five
missense SNPs in MPD were not confirmed by our data,
including three that had full sequence coverage in our
data and were determined to have identical D2 and B6
alleles. Our data indicate that these three are false positive
missense SNPs in the public dataset: Fcgr2b  (K203Q),BMC Genomics 2009, 10:379 http://www.biomedcentral.com/1471-2164/10/379
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Fcgr3 (A81S), Itln1 (Y133F). The other two had ambigu-
ous coverage in our alignments and could not be evalu-
ated: Fcgr3 (G72W) and Itln1 (N162K).
In addition to the new missense SNPs, we identified 7,627
new PARC SNPs in non-coding regions. These SNPs were
not previously known or annotated and may regulate
gene and/or protein expression. For example, in the Kcnj9
gene, which demonstrates differential transcript expres-
sion between the D2 and B6 strains [13], we identified 18
new SNPs within 2 kb upstream of the transcriptional
start site as well as nine new SNPs in the 3' untranslated
region (Figure 5). We also identified one false-positive
SNP annotated in MPD in the 3' untranslated region.
Thus, for Kcnj9 and other differentially expressed genes,
elucidation of cryptic SNPs could identify nucleotide var-
iation that underlies QTL phenotypic effects.
SNP impact on gene expression microarrays
Naturally occurring genetic polymorphisms dramatically
impact hybridization based techniques, including gene
expression microarray analyses [14]. With the ability to
assess alternative transcript expression, exon microarrays
have ten times as many probes as previous gene expres-
sion microarrays, so eliminating hybridization bias using
SNP masks is increasingly critical. We have developed and
applied a complete SNP mask using all of the PARC SNPs
found by our custom HTS, which allowed us to rigorously
assess differential expression between the D2 and B6
strains. We assessed the impact of 124 SNPs that lie within
core probesets on the detection of differential (genotype-
dependent) exon expression for genes in the chromosome
1 region of interest using Affymetrix Mouse Exon 1.0 ST
array data (for details, please see Mooney et al., compan-
ion publication). 629 core probesets interrogate this inter-
val. When compared to our unmasked data, masked
results were consistent for 141 differentially expressed
probesets and 437 non-differentially expressed probesets,
but indicated 47 false positive and 4 false negative results
due to SNPs.
Furthermore, we overlaid D2 vs. B6 SNPs discovered by
our custom HTS with the probe locations of all four types
of probesets within the chromosome 1 interval (i.e., core,
extended, full, and free) for the Affymetrix Exon 1.0 ST
gene expression microarray platform. For chromosome 1
(171.6 – 174.6 Mb), there are 8201 probes and 2126
probesets on the Affymetrix Mouse Exon 1.0 ST array, and
we identified 861 probes that spanned at least one SNP
encompassing 480 probesets or 23% of the probesets that
interrogate this interval (unpublished data). Thus, com-
pared to publicly available D2 vs. B6 SNPs, custom HTS
identified 60% more probesets that span SNPs.
Conclusion
We report that comparisons utilizing even two of the most
commonly used mouse genetic models, D2 and B6, pre-
dict that more than half of naturally-occurring SNPs
remain unknown or not annotated. This is particularly
striking given that the present comparison is between the
B6 strain, upon which the mouse reference is based [7],
and the D2 strain, which is one of the best annotated
mouse strains with sequence from Celera and extensive
SNP detection data primarily from Perlegen [1]. There are
approximately 1.8 million SNPs currently annotated
between the D2 and B6 strains in MPD [14]. Thus, cryptic
SNPs would have been even more prevalent had we used
more divergent or poorly annotated genetic models.
We compare two methods for next-generation HTS. By
sequencing the same templates on both Applied Biosys-
tems' SOLiD and Illumina's Genome Analyzer sequencing
platforms, we determined that the platforms offer compa-
rable results at a high read depth. More SNPs were called
by Illumina/Maq than by Applied Biosystems, but
because the vendors used independent mapping and SNP
calling approaches, differential results are likely due to
Read depth for Applied Biosystems' SOLiD (red) and Illu- mina's Genome Analyzer (blue) realignments Figure 2
Read depth for Applied Biosystems' SOLiD (red) and 
Illumina's Genome Analyzer (blue) realignments. For 
D2 and B6 strains for the 171.6–174.6 Mb region of chromo-
some 1, each tick indicates the average read depth within the 
corresponding 25,000 bp bin.
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differences in the analysis pipelines, as no nucleotide bias
in the frequency of the calls made by the Genome Ana-
lyzer and SOLiD was apparent.
Mouse models are an invaluable tool for identifying
allelic variation that contributes to genetically determined
differences in physiology and behavior. However, allelic
variation is problematic for follow-up analyses, and
removing technical bias resulting from naturally-occur-
ring sequence variation is critical. Previously, we illus-
trated the impact of SNPs on gene expression microarray
analyses [14] and argued that complete SNP masks for
gene expression microarray and other hybridization tech-
niques are essential to appropriately interpret these data.
Here, we have taken the next step and sequenced a region
of two of the most widely used mouse strains in order to
determine the comprehensiveness of SNP data. What we
have found is that the mouse SNP data currently available
is incomplete. In fact, for the D2 vs. B6 strains, we predict
that less than half of the true SNPs are currently anno-
tated. As more divergent mouse strains, harboring even
more cryptic SNPs, are used in studies, the impact of SNPs
on interpreting results will become increasingly problem-
atic. This glimpse at complete sequence data for two
strains demonstrates that full genomic sequencing of the
mouse strains used as research models is warranted.
Methods
D2 BAC library screen
Using 32 chemiluminescent labeled PCR probes designed
across a 3 Mb region of chromosome 1 (see Additional
File 1 for PCR probe primer pairs), we systematically
probed a D2 BAC library consisting of 215,040 clones
spotted on 12 nylon filters. The MM_DBa BAC library was
generated at Clemson University Genome Institute [15] in
2002 using a single male D2 strain mouse from the Jack-
son Laboratory where their Genetic Stability Program uses
a cryopreservation approach to effectively limit genetic
drift and ensure strain stability. 90 BACs were identified in
the library screen using the standard Roche DIG chemilu-
minescent protocol for probing DNA library filters.
D2 BAC end sequencing
BAC ends were sequenced in order to determine if we had
overlap. This was done in several rounds, in which we
Table 1: Comparison of Illumina and Applied Biosystems realignment data.
Illumina SOLiD
B6 D2 B6 D2
Total basepairs covered 2898101 3000000 2898101 3000000
Ns in realignment 547 23207 82499 116135
Realignment discrepancies to B6 reference or SNPs detected in D2 128 11221 41 9823
Ambiguous alleles 244 2047 37 635
Results are based upon realignments performed by each vendor for chromosome 1 (171.6–174.6 Mb). N's indicate a 'no call' in the realignment. 
Realignment discrepancies to B6 reference indicate a mismatch to the reference sequence, and SNP detection in D2 indicates a different allele than 
the B6 reference sequence. An ambiguous allele indicates that more than one base was called at that base, and since these are inbred animals, those 
calls are ignored and considered the same as a no call or an 'N'.
D2 vs. B6 SNPs and B6 realignment discrepancies vs. refer- ence sequence Figure 3
D2 vs. B6 SNPs and B6 realignment discrepancies vs. 
reference sequence. Custom HTS of chromosome 1 
(171.6 – 174.6 Mb) data reveals D2 vs. B6 PARC SNPs and 
realignment discrepancies when compared to the B6 refer-
ence sequence. A) B6 vs. D2 PARC SNPs identified by Illu-
mina's realignment of Genome Analyzer data (blue circle) 
and/or Applied Biosystems' realignment of SOLiD data (red 
circle). D2 vs. B6 SNPs annotated in the Mouse Phenome 
Database (MPD) are also illustrated for comparison (green 
circle). Of the 11,824 PARC SNPs found using custom HTS 
by at least one sequencing method, 7,663 were previously 
unknown or not annotated as D2. vs. B6 SNPs, demonstrat-
ing that public data for D2 vs. B6 SNPs is currently far from 
complete. B) Identification of 12 and 31 provisional discrep-
ancies in the comparison of the B6 reference sequence to 
Illumina's (blue circle) and Applied Biosystems' (red circle) 
realignments; and confirmation (i.e., detected by both HTS 
platforms) of realignment discrepancies at 29 positions when 
compared to reference sequence.BMC Genomics 2009, 10:379 http://www.biomedcentral.com/1471-2164/10/379
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Density of PARC SNPs and protein coding genes Figure 4
Density of PARC SNPs and protein coding genes. B6 vs. D2 PARC SNPs are binned in 5000 bp intervals. The blue lines 
indicate how many SNPs are currently annotated in the public MPD database, and the red lines show how many PARC SNPs 
were discovered by custom HTS with realignment of this 3 Mb interval of chromosome 1. SNP dense and SNP sparse regions 
are apparent. A total of only 16 SNPs were detected between 171.6 – 172.9 Mb, whereas 11,808 SNPs were detected between 
172.9 – 174.6 Mb. Below, the black blocks identify the locations of the 79 protein coding genes annotated by Ensembl in this 
interval.
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Table 2: Missense B6 vs. D2 PARC SNPs discovered by custom HTS.
SNP identifier Build 37
Chromosome 1
location (bp)
Gene Ensembl Protein
ID(ENSMUS)
Amino acid
change
SIFT PolyPhen
PARCsnp_1.001151 172981853 Fcgr3 P00000027964 D244E tolerated benign (A)
PARCsnp_1.008771 173088929 Mpz P00000066701 T94A tolerated benign (A+S)
PARCsnp_1.011031,2 173126252 Pcp4l1 P00000049205 A40T unknown benign (A)
PARCsnp_1.015781,2,4 173186807 Adamts4 P00000006570 F574Y tolerated benign (A)
PARCsnp_1.017351 173214749 Usp21 P00000064002 C341R tolerated benign (A)
PARCsnp_1.020571 173268767 Nit1 P00000106927 L236R* damaging probably damaging (A)
PARCsnp_1.021491,4 173290449 Klhdc9 P00000056212 E115G* tolerated probably damaging (A)
PARCsnp_1.022521 173300263 Pvrl4 P00000106917 S12T unknown benign (A)
PARCsnp_1.025094 173335292 Arhgap30 P00000059389 L458S tolerated benign (A)
PARCsnp_1.032023,4 173433896 Refbp2 P00000080242 R37S* tolerated possibly damaging (A)
PARCsnp_1.03321 173446982 novel P00000048799 L84V unknown benign (A)
PARCsnp_1.14401 173503917 Cd244 P00000004829 T56K tolerated benign (A+S)
PARCsnp_1.037241 173503965 Cd244 P00000004829 D72G tolerated benign (A+S)
PARCsnp_1.037251 173504048 Cd244 P00000004829 K100Q tolerated benign (A+S)
PARCsnp_1.144055 173504085 Cd244 P00000004829 T112I* tolerated probably damaging (A+S)
PARCsnp_1.03726 173504100 Cd244 P00000004829 K117R tolerated benign (A+S)
PARCsnp_1.037271,5 173504109 Cd244 P00000004829 N120T tolerated benign (A+S)
PARCsnp_1.037331,4 173504395 Cd244 P00000004829 I186T tolerated benign (A)
PARCsnp_1.03736 173504497 Cd244 P00000004829 S220L tolerated benign (A)
PARCsnp_1.14470 173510893 Cd244 P00000004829 S333F* damaging benign (A)
PARCsnp_1.039961 173537415 Ly9 P00000004827 G14S tolerated benign (A)
PARCsnp_1.056321,4 173826546 anon P00000095074 T98A unknown benign (A)
PARCsnp_1.161624 173826619 anon P00000095074 G122E unknown benign (A)
PARCsnp_1.067891,2,3,5 174012752 Ncstn P00000003550 S21F tolerated benign (A)
PARCsnp_1.067061,2,4 173996899 Ncstn P00000003550 T678I* tolerated possibly damaging (A)
PARCsnp_1.067052,4 173996894 Ncstn P00000003550 V680I tolerated benign (A)
PARCsnp_1.069901,2,4 174044893 Copa P00000027833 S761T* tolerated possibly damaging (A)BMC Genomics 2009, 10:379 http://www.biomedcentral.com/1471-2164/10/379
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designed new probes as needed to fill in gaps in our 3 Mb
contig. In total, we sequenced the ends of the 99 BAC
clones and aligned these BAC end-sequences to the refer-
ence mouse sequence. Given that the stringency of the fil-
ter hybridizations was variable, that interpretation of
positive filter spots was not always straightforward, and
that the quality of BAC end-sequencing was not always
consistent, we proceeded to confirm each clone we iden-
tified. We confirmed a BAC as positive for our region if the
end-sequence mapped uniquely to the region of chromo-
some 1, and the PCR probe mapped in between the end
sequences. We confirmed 57 positive BACs for the chro-
mosome 1 region and aligned these to create a minimal
contig of 27 overlapping MM_DBa BACs: clones 75C22,
329K2, 163C23, 109M5, 438J2, 138A14, 372P6, 264L1,
69J19, 220P1, 196G24, 250H1, 17F16, 374A8, 271K8,
467L22, 405D20, 431P3, 359G4, 259B4, 246D12,
248E11, 270C10, 440I3, 98C12, 41K6, and 306F23.
B6 BAC identification
For the B6 BAC contig, we used the RPCI-23 B6 Mouse
BAC Library available from Children's Hospital Oakland
Research Institute [16], which was generated from a pool
of five female B6 strain mice from the Jackson Laboratory,
where strain stability is carefully controlled. This is the
same library used by the Mouse Genome Sequencing
Consortium to generate the B6 reference strain sequence.
We used publically available BAC end-sequence for the
BAC clones and assembled a minimal contig of 25 over-
lapping BACs including clones 27N12, 162D2, 90F16,
135E8, 161F18, 244J9, 247E12, 311M1, 354B19, 31N9,
395H6, 231O3, 362G20, 21D8, 295F11, 277L8, 125N14,
447P5, 58C22, 477M10, 22H23, 454E7, 411M14,
131N14, and 6N10.
DNA preparation
Once the clones were identified, the same DNA prepara-
tion protocol was used for the D2 and B6 BAC clones. Vec-
PARCsnp_1.070031,2,3,5 174049099 Copa P00000027833 N984S tolerated benign (A)
PARCsnp_1.077794 174185185 Atp1a4 P00000007346 I74V tolerated benign (A)
PARCsnp_1.076931,4 174174231 Atp1a4 P00000007346 N476S tolerated benign (A)
PARCsnp_1.076641,4 174170189 Atp1a4 P00000007346 M546T tolerated benign (A)
PARCsnp_1.083791,2,4 174247711 Igsf8 P00000041232 H221R tolerated benign (A)
PARCsnp_1.083891,2 174248843 Igsf8 P00000041232 T489S tolerated benign (A)
PARCsnp_1.088381,2,4 174299836 Kcnj10 P00000054356 T262S tolerated benign (A)
PARCsnp_1.098311,4 174415000 Igsf9 P00000058275 H49R* tolerated possibly damaging (A)
PARCsnp_1.10673 174530187 Fcrl6 P00000091861 E11D tolerated benign (A)
Thirty-six of the seventy-six missense PARC SNPs between the D2 and B6 strains detected by custom HTS were not previously annotated in MPD. 
Confirmed SNPs are defined as those SNPs detected using two or more independent methods, including the Illumina and Applied Biosystems 
methods presented here. 30 of the 36 missense SNPs have been confirmed by one or more datasets. 1confirmed by both Illumina and Applied 
Biosystems sequencing pipelines, 2confirmed by transcriptome sequencing (see Methods), 3confirmed by PCR directed sequencing [6], 4confirmed 
by realignment of Celera raw reads (see SNP Databases in Methods), or 5supported by imputed SNPs [24]. Ensembl protein IDs and respective 
amino acid differences are shown with the B6 amino acid residue indicated first and the D2 residue given last. Each amino acid change was assessed 
using two programs to determine whether or not the amino acid change is predicted to damage protein function. SIFT uses sequence conservation 
for predictions and PolyPhen predicts damaging changes using both multiple sequence alignments (A) and/or protein 3D structures (S).
Table 2: Missense B6 vs. D2 PARC SNPs discovered by custom HTS. (Continued)
Kcnj9 B6 vs. D2 PARC SNPs Figure 5
Kcnj9 B6 vs. D2 PARC SNPs. Kcnj9 is represented with 
the coding region shown in the gray boxes and the 5' and 3' 
untranslated regions (UTRs) in the white boxes. Introns are 
illustrated as V-lines, and upstream region as a horizontal 
black line. The blue lines indicate SNPs found in MPD that we 
confirmed by custom HTS (PARC SNPs). The red lines indi-
cate previously cryptic SNPs, i.e., new PARC SNPs. For Kcnj9 
(ENSMUST00000062387), we found nine new SNPs in the 3'-
UTR, and 18 new SNPs in the 2 kb upstream region, and 
identified one false positive SNP (green line) in the 3'-UTR. In 
addition, we confirmed six synonymous coding SNPs, eleven 
3'-UTR SNPs, one 5'-UTR SNP, and 5 SNPs within 2 kb 
upstream of the transcription start site. Additionally, within 
the introns, we identified 15 new SNPs and confirmed 28 
SNPs (not shown).
exon 1 exon 2
Kcnj9
exon 3 exon 4
MPD SNP confirmed by PARC SNP
PARC SNP identified
False positive SNPBMC Genomics 2009, 10:379 http://www.biomedcentral.com/1471-2164/10/379
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tors were not removed. Each clone was prepared from a
glycerol stock by Clemson University using a standard
protocol [15]. This resulted in high-quality end-sequence
data. We quantified the BAC DNA using a Nanodrop 1000
(Thermo Scientific) and assessed quality of the 260/280
ratios of each BAC clone. For each of two final samples
(B6 and D2), BACs were pooled equimolarly and sent to
Applied Biosystems (Foster City, CA) and Illumina (San
Diego, CA) for next-generation short read DNA sequenc-
ing.
Illumina (Genome Analyzer) sequence and assembly
As per Illumina's requirements, equimolarly pooled BAC
DNA was submitted for each B6 and D2 samples: 8.5 ug
of B6 BACs and 22.8 ug of D2 BACs. Illumina prepared
single read libraries and performed sequencing on the
Genome Analyzer I (previously, Solexa) as per standard
protocol [17]. Briefly, the sequencing process relies on the
amplification of fragmented DNA to form clusters. The
sequence content of these clusters is then queried using
cycles of fluorescently labeled dNTP addition, detection,
and fluorescent groupremoval. The data was optimally
assembled by Illumina using Maq (Mapping and Assem-
bly with Quality) [18] with the default parameters in the
easyrun script [9]. We used the cns.final.snp output file
with minimum read depth of 3 and minimum consensus
quality of 30 required to call a SNP for these analyses.
Applied Biosystems (SOLiD) sequence and assembly
Equimolarly pooled BAC DNA samples were sent to
Applied Biosystems as per their requirements: 49.7 ug of
B6 BACs and 69.3 ug of D2 BACs. Applied Biosystems pre-
pared two fragment libraries for sequencing from each
pool of genomic DNA via standard methods on their
SOLiD platform [19]. In short, the SOLiD process attaches
clonally-amplified template DNA to a bead and adapter
substrate and queries cyclically by adding fluorescently
labeled probes specific to two bases, detecting these di-
base-calls, removing the fluorescent group, and repeating.
This is followed by a primer-reset which shifts the starting
primer, allowing different bases to be queried using the
above base-calling cycle.SOLiD data was analyzed by
Applied Biosystems using their freely available software
package. The SOLiD Analysis Tools (SAT) process the
array image, perform data filtering, calculate quality val-
ues, align to a reference genome, and generate base calls
using default parameters [20]. SNPs were called with a
minimum read depth of 3 as a requirement.
Determining non-synonymous SNPs
Non-synonymous SNPs were computed using the
Ensembl CDS sequence from UCSC for each transcript.
Any SNP falling within coding region and the exon
boundaries were used to convert the B6 allele into the D2
allele predicted by the realignments. The coding
sequences were then reassembled and translated in silico
using CLC Sequence Viewer 5 [21]. The amino acid
sequences were compared and any differences were noted.
Transcriptome sequencing
Striatal tissue from D2 (n = 8) and B6 (n = 8) males and
females was dissected and total RNA isolated using stand-
ard Trizol (Invitrogen) protocol. 3 μg of total RNA was
pooled (n = 8) for each strain and sent to Illumina for
library construction and standard transcriptome sequenc-
ing. The realignment was performed using ELAND with 2
errors allowed in the first 32 bases of a read. Because we
had incomplete read coverage for lowly expressed genes,
strain-specific sequence results were analyzed for highly
expressed genes only. So this dataset offers confirmation
of some of the SNPs detected in our DNA sequencing, but
did not achieve complete transcriptome coverage.
SNP Databases
1. Mouse Phenome database (MPD). The MPD SNP
collection [22] contains data for approximately 10
million mouse SNPs for an expansive list of strains
from a variety of sources, including datasets such as
Broad Institute and Wellcome Trust that are not yet
available in other databases. A significant portion of
these SNPs are from Perlegen (NIEHS) [1]. Genotype
allele tables are generally provided by investigators;
however, Perlegen did not include B6 in their analyses.
In this case, MPD annotated the reference B6 alleles
with the Perlegen data making SNP queries including
the B6 strain more inclusive. Specifically, MPD has
4,527 D2 vs. B6 SNPs in the chromosome 1 interval
(171.6–174.6 Mb) of interest. All SNPs are mapped to
NCBI mouse genome build 37.1 reference assembly
(B6). This MPD SNP data build includes annotation
from dbSNP 128, Ensembl 48, and NCBI extracted
during Dec 2007. The 18 strains with high density SNP
data are B6, D2, 129S1/SvImJ, A/J, AKR/J, BALB/cByJ,
BTBR_T+_tf/J, C3H/HeJ, CAST/EiJ, FVB/NJ, KK/HlJ,
MOLF/EiJ, NOD/ShiLtJ, NZW/LacJ, PWD/PhJ, WSB/
EiJ, 129X1/SvJ, and CZECHII/EiJ.
2. dbSNP Build 128. dbSNP is maintained at NCBI
[23] and includes more than 14 million mouse SNPs.
When querying for strain specific polymorphisms,
dbSNP identifies 2,903 D2 vs. B6 SNPs in the chromo-
some 1 interval (171.6–174.6 Mb) of interest. This
number is significantly lower than those found in
MPD because the Perlegen data does not include B6
alleles, so dbSNP does not retrieve these in the strain
specific queries.
3. Ensembl variation 53. The Ensembl SNP dataset is
queried using Biomart [24] and primarily incorporates
dbSNP 128. There are some additional SNPs specificBMC Genomics 2009, 10:379 http://www.biomedcentral.com/1471-2164/10/379
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to Ensembl without reference SNP (rs) accession num-
bers. When querying for strain specific polymor-
phisms, Ensembl retrieves 2,832 D2 vs. B6 SNPs in the
chromosome 1 interval (171.6–174.6 Mb) of interest.
Additionally, individual transcript queries in Ensembl
include strain variation data that contain realignments
of the original strain specific raw reads from Celera
(including D2) to the reference B6 sequence. These
SNPs provide independent confirmation of some of
the SNPs identified by custom HTS and are annotated
as confirmation by "Realignment of Celera raw reads"
in Table 2.
Data availability
All of the PARC SNPs discovered from both Applied Bio-
systems' SOLiD and Illumina's Genome Analyzer
sequencing pipelines have been deposited in dbSNP at
NCBI under the Handle PARC_SEQ as Computational
SNPs (ss#119994841-120015816). D2 BAC end
sequence has been submitted to GenBank as GSS
(genome survey sequences). Raw sequencing data for
SOLiD sequencing has been submitted to GenBank in the
SRA (short read archive) without intensity data. Raw
sequencing data for the Illumina sequencing is available
upon request; however this data was generated before SRA
standards were established, and the specific raw files
needed for SRF format are no longer available.
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